Reaction

Acute Lymphocytic Leukaemia Recurrent reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,549 reports · 60 co-occurring drugs

As of the last recalculation, Acute Lymphocytic Leukaemia Recurrent appears in 2,549 FAERS reports alongside 60 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 1,494.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Blinatumomab	1,092	1,494.4	1,670.1
Imatinib	203	102.0	103.2
Thiotepa	86	76.1	76.8
Fludarabine Phosphate	294	68.9	69.4
Mercaptopurine	129	63.9	64.4
Cytarabine	360	56.8	57.1
Dasatinib	228	54.9	55.2
Busulfan	101	54.5	54.9
Pegaspargase	48	32.6	32.7
Vincristine Sulfate	100	29.0	29.1
Anti-Thymocyte Globulin (Rabbit)	28	28.6	28.7
Cyclophosphamide Injection, Solution	430	23.7	23.7
Cyclophosphamide	430	23.7	23.7
Cyclophosphamide For Injection	430	23.7	23.7
Micafungin Sodium	24	23.3	23.4
Nilotinib	78	22.2	22.3
Doxorubicin	174	17.0	17.1
Dexamethasone Sodium Phosphate	21	17.0	17.0
Filgrastim	75	16.7	16.8
Posaconazole	31	15.8	15.8
Ursosiol	36	15.3	15.4
Posaconazole Delayed-Release	20	15.0	15.0
Melphalan Hydrochloride	45	14.9	14.9
Voriconazole	52	14.2	14.3
Dexamethasone 1.5 Mg	429	14.2	14.2
Voriconazole Injection	37	14.1	14.1
Ursodiol	37	14.1	14.1
Dexamethasone	429	14.0	14.0
Cefepime Hydrochloride	27	13.8	13.8
Cefepime	24	13.8	13.8
Etoposide	106	12.2	12.3
Melphalan	33	12.0	12.0
Mesna Injection	12	11.9	11.9
Mesna	12	11.7	11.7
Imatinib Mesylate	39	11.6	11.6
Sodium Bicarbonate	32	11.4	11.4
Sodium Bicarbonate Injection,	32	11.4	11.4
Phytonadione	11	10.6	10.6
Methotrexate Sodium	515	10.6	10.6
Methotrexate	449	10.4	10.4
Doxorubicin Hydrochloride	37	9.4	9.4
Acyclovir	114	8.5	8.5
Sulfamethoxazole And Trimethoprim	83	8.3	8.3
Cyclosporine	104	7.9	7.9
Amphotericin B	12	7.9	7.9
Hydroxyurea	18	7.0	7.0
Hydrocortisone Sodium Succinate	8	7.0	7.0
Ganciclovir	8	6.4	6.4
Bosutinib	7	6.4	6.4
Granisetron Hydrochloride	8	6.3	6.3
Ganciclovir Sodium	8	6.2	6.2
Atovaquone	6	6.1	6.1
Alteplase	10	5.5	5.5
Valacyclovir	25	4.9	4.9
Venetoclax	32	4.3	4.3
Entecavir	5	3.5	3.5
Ifosfamide	9	3.4	3.4
Romiplostim	5	2.7	2.7
Azacitidine For	6	2.7	2.7
Daptomycin	3	2.7	2.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.